Compiled by Tin Geber for HIVOS. London, March 2018
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
PLOS ONE | www.plosone.org 1
December 2013 | Volume 8 | Issue 12 | e82027
Mapping Report - Catalonia (Spain).
Second Edition
AIDS Medicines and diagnostics services
July 2015
An international field study by African and German Theologicans and health workers
Indonesia's National Action Plan for Prevention of Mother to Child HIV Transmission 2013-2017
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
J Epidemiol Community Health 2011;65:1166e1170. doi:10.1136/jech.2009.097469
Topics in Antiviral Medicine Volume 25 Issue 2 May/June 2017
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...ses and to identify the predictive factors of the first change of ARV treatment in Senegal.
more
The WHO Global strategy on human resources for health: workforce 2030 encourages development partners and global health initiatives to leverage their support to health systems in countries to sustainably strengthen the health workforce. To assess the impact of these investments, a methodology was de...veloped and pilot tested by WHO.
The impact assessment tool (consisting of an MS Excel calculator with two subsets) supports users to:
• assess and quantify the health impact of HRH investments made in the context of HIV, tuberculosis (TB) and malaria programmes through their modelled effect on health service coverage of these three diseases; and
• provide aggregate indicative estimates of the range of health workers required to attain high coverage of selected health services.
more